MRTX Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Proposed Sale of Mirati Therapeutics, Inc. to Bristol Myers Squibb
20 oct. 2023 09h01 HE | Wohl & Fruchter LLP
MONSEY, N.Y., Oct. 20, 2023 (GLOBE NEWSWIRE) -- The law firm of Wohl & Fruchter LLP is investigating the fairness of the proposed sale of Mirati Therapeutics, Inc. (Nasdaq: MRTX) (“Mirati”) to...
Picture1.png
Autolus Therapeutics Announces Collaboration with Bristol Myers Squibb for Use of Autolus’ Proprietary Safety Switch System
04 oct. 2022 07h00 HE | Autolus Therapeutics plc
- Bristol Myers Squibb to receive access to Autolus’ RQR8 safety switch for use in cell therapy programs - - Autolus to receive an upfront payment, with potential for near term option...
BES_Mark.jpg
TURNING POINT THERAPEUTICS ALERT: Bragar Eagel & Squire, P.C. Investigates Merger of TPTX and Encourages Investors to Contact the Firm
06 juin 2022 14h19 HE | Bragar Eagel & Squire
NEW YORK, June 06, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, has launched an investigation into whether the officers or directors...
Simio Sync 2022: Practical Applications Comes to a Successful Conclusion
10 mars 2022 14h00 HE | Simio LLC
PITTSBURGH, March 10, 2022 (GLOBE NEWSWIRE) -- Simio is delighted to announce the successful conclusion of its fifth Simio Sync event titled "Practical Applications". The virtual conference...
Triphase-logo-Web.png
Triphase Accelerator Announces Positive Interim Results of Phase 1 Trial of TRPH-222 in Patients with Relapsed/Refractory Non-Hodgkin Lymphoma
07 déc. 2020 16h30 HE | Triphase Accelerator
TORONTO and SAN DIEGO, Dec. 07, 2020 (GLOBE NEWSWIRE) -- Triphase Accelerator, a private drug development company dedicated to advancing novel compounds through clinical proof-of-concept, today...
PDF to PNG Logo.png
SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation of MyoKardia, Inc. Buyout
05 oct. 2020 21h00 HE | Rigrodsky & Long, P.A.
WILMINGTON, Del., Oct. 05, 2020 (GLOBE NEWSWIRE) -- Rigrodsky & Long, P.A. announces that it is investigating MyoKardia, Inc. (“MyoKardia”) (NASDAQ GS: MYOK) regarding possible breaches of...
BES_Mark.jpg
MYOKARDIA ALERT: Bragar Eagel & Squire, P.C. Investigates Sale of MYOK and Encourages Investors to Contact the Firm
05 oct. 2020 14h57 HE | Bragar Eagel & Squire
NEW YORK, Oct. 05, 2020 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, has launched an investigation into whether the board members of...
logo-alt.png
Global Antidepressant Market: Increased Stress Levels over the Covid-19 Outbreak - PMI
30 juin 2020 10h40 HE | PMI
Covina, CA, June 30, 2020 (GLOBE NEWSWIRE) -- The global antidepressant market accounted for US$ 13.2 billion in 2019 and is estimated to be US$ 26.1 billion by 2029 and is anticipated to register a...
jounce.png
Jounce Therapeutics Regains Worldwide Rights to JTX-8064 from Bristol Myers Squibb
04 juin 2020 08h00 HE | Jounce Therapeutics, Inc.
CAMBRIDGE, Mass., June 04, 2020 (GLOBE NEWSWIRE) -- Jounce Therapeutics, Inc. (NASDAQ: JNCE), a clinical-stage company focused on the discovery and development of novel cancer immunotherapies and...
Hausfeld logo
Celgene Rescinds Agreement to Compensate Cancer Patients Days Before Christmas
08 janv. 2020 13h36 HE | Hausfeld
WASHINGTON, Jan. 08, 2020 (GLOBE NEWSWIRE) -- On December 23, 2019, Celgene backed out of a settlement in which it had agreed to pay $55 million to end payors (consumers, insurers, union health and...